Literature DB >> 18448623

Human serum contains a protease that protects against cytotoxic activity of Bacillus anthracis lethal toxin in vitro.

David L Goldman1, WangYong Zeng, Johanna Rivera, Antonio Nakouzzi, Arturo Casadevall.   

Abstract

The role of innate immunity in the host response to Bacillus anthracis is poorly understood. We found that normal human serum contains an antitoxin mechanism that is capable of protecting macrophages in vitro from B. anthracis lethal toxin-mediated killing. This protective activity was limited to defined amounts of toxin and was lost by heat treatment or serum dilution. Some person-to-person variation in the protective activity of serum was noted, especially with higher concentrations of lethal toxin. A similar protective activity was found in murine serum, though human serum consistently neutralized more toxin than did murine serum. The protective activities of both murine and human sera correlated with cleavage of the protective antigen into two fragments with approximate molecular sizes of 20 and 50 kDa that were recognized by the monoclonal antibodies 7.5G and 10F4, respectively. This pattern of fragmentation is consistent with cleavage at multiple sites, including the furin-susceptible site. Cleavage was abolished by heat treatment and calcium chelation. These findings highlight a potential role for serum proteases in protection against the lethal toxin of B. anthracis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18448623      PMCID: PMC2446628          DOI: 10.1128/CVI.00064-08

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  15 in total

1.  Serum proteases alter the antigenicity of peptides presented by class I major histocompatibility complex molecules.

Authors:  L D Falo; L J Colarusso; B Benacerraf; K L Rock
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

2.  A monoclonal antibody to Bacillus anthracis protective antigen defines a neutralizing epitope in domain 1.

Authors:  Johanna Rivera; Antonio Nakouzi; Nareen Abboud; Ekaterina Revskaya; David Goldman; R John Collier; Ekaterina Dadachova; Arturo Casadevall
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

3.  Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: a randomized, double-blinded, controlled, multicenter trial.

Authors:  Geoffrey J Gorse; Wendy Keitel; Harry Keyserling; David N Taylor; Michael Lock; Katia Alves; Julie Kenner; Lynne Deans; Marc Gurwith
Journal:  Vaccine       Date:  2006-06-05       Impact factor: 3.641

4.  Degradation of type I and II collagen by human activated C1-s.

Authors:  K Yamaguchi; H Sakiyama; M Matsumoto; H Moriya; S Sakiyama
Journal:  FEBS Lett       Date:  1990-07-30       Impact factor: 4.124

5.  Serum protease cleavage of Bacillus anthracis protective antigen.

Authors:  J W Ezzell; T G Abshire
Journal:  J Gen Microbiol       Date:  1992-03

6.  The pathogenesis of the lethal effect of anthrax toxin in the rat.

Authors:  F A Beall; F G Dalldorf
Journal:  J Infect Dis       Date:  1966-06       Impact factor: 5.226

7.  The complement component C1s is the protease that accounts for cleavage of insulin-like growth factor-binding protein-5 in fibroblast medium.

Authors:  W H Busby; T J Nam; A Moralez; C Smith; M Jennings; D R Clemmons
Journal:  J Biol Chem       Date:  2000-12-01       Impact factor: 5.157

8.  Detection and quantification of anthrax lethal factor in serum by mass spectrometry.

Authors:  Anne E Boyer; Conrad P Quinn; Adrian R Woolfitt; James L Pirkle; Lisa G McWilliams; Karen L Stamey; Dennis A Bagarozzi; John C Hart; John R Barr
Journal:  Anal Chem       Date:  2007-10-12       Impact factor: 6.986

9.  Anthrax protective antigen cleavage and clearance from the blood of mice and rats.

Authors:  Mahtab Moayeri; Jason F Wiggins; Stephen H Leppla
Journal:  Infect Immun       Date:  2007-08-27       Impact factor: 3.441

10.  Anthrax toxin-induced shock in rats is associated with pulmonary edema and hemorrhage.

Authors:  Shu-Ru Kuo; Mark C Willingham; Sarah H Bour; Elissa A Andreas; Seong Kyu Park; Carney Jackson; Nicholas S Duesbery; Stephen H Leppla; Wei-Jen Tang; Arthur E Frankel
Journal:  Microb Pathog       Date:  2007-12-23       Impact factor: 3.738

View more
  9 in total

1.  Methylxanthine inhibit fungal chitinases and exhibit antifungal activity.

Authors:  Kalliope Tsirilakis; Christy Kim; Alfin G Vicencio; Christopher Andrade; Arturo Casadevall; David L Goldman
Journal:  Mycopathologia       Date:  2011-10-04       Impact factor: 2.574

2.  Anthrax toxin receptor 1/tumor endothelial marker 8: mutation of conserved inserted domain residues overrides cytosolic control of protective antigen binding.

Authors:  Jordan D Ramey; Valerie A Villareal; Charles Ng; Sabrina C Ward; Jian-Ping Xiong; Robert T Clubb; Kenneth A Bradley
Journal:  Biochemistry       Date:  2010-08-31       Impact factor: 3.162

3.  Anthrax toxin triggers the activation of src-like kinases to mediate its own uptake.

Authors:  Laurence Abrami; Béatrice Kunz; F Gisou van der Goot
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

4.  Effects of introducing a single charged residue into the phenylalanine clamp of multimeric anthrax protective antigen.

Authors:  Blythe E Janowiak; Audrey Fischer; R John Collier
Journal:  J Biol Chem       Date:  2010-01-08       Impact factor: 5.157

5.  Platelet-activating factor contributes to Bacillus anthracis lethal toxin-associated damage.

Authors:  Johanna Rivera; Rani S Sellers; Wangyong Zeng; Nico van Rooijen; Arturo Casadevall; David L Goldman
Journal:  J Biol Chem       Date:  2014-01-29       Impact factor: 5.157

6.  Lethal factor, but not edema factor, is required to cause fatal anthrax in cynomolgus macaques after pulmonary spore challenge.

Authors:  Julie A Hutt; Julie A Lovchik; Melissa Drysdale; Robert L Sherwood; Trevor Brasel; Mary F Lipscomb; C Rick Lyons
Journal:  Am J Pathol       Date:  2014-10-05       Impact factor: 4.307

7.  Mouse, but not human, ApoB-100 lipoprotein cholesterol is a potent innate inhibitor of Streptococcus pneumoniae pneumolysin.

Authors:  Kristin R Wade; Eileen M Hotze; David E Briles; Rodney K Tweten
Journal:  PLoS Pathog       Date:  2014-09-04       Impact factor: 6.823

8.  Serum-Mediated Cleavage of Bacillus anthracis Protective Antigen Is a Two-Step Process That Involves a Serum Carboxypeptidase.

Authors:  David L Goldman; Edward Nieves; Antonio Nakouzi; Johanna Rivera; Ei Ei Phyu; Than Htut Win; Jacqueline M Achkar; Arturo Casadevall
Journal:  mSphere       Date:  2018-06-27       Impact factor: 4.389

9.  Binding of the von Willebrand Factor A Domain of Capillary Morphogenesis Protein 2 to Anthrax Protective Antigen Vaccine Reduces Immunogenicity in Mice.

Authors:  Fabiana Freire Mendes de Oliveira; Sireesha Mamillapalli; Srinivas Gonti; Robert N Brey; Han Li; Jarad Schiffer; Arturo Casadevall; James G Bann
Journal:  mSphere       Date:  2020-01-15       Impact factor: 4.389

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.